)
Vadodara based pharmaceutical firm posted a 40 per cent rise in net profit after tax to Rs 61.3 crore in the fourth quarter of 2013-14 fiscal mainly on the back of robust growth in the international generic formulation business.
Net sales is up by 23 per cent to Rs 465.2 crore against Rs 378.4 crore in the corresponding quarter last year. Profit before tax up by 46 per cent to Rs 80.8 crore against Rs 55.2 crore in the corresponding quarter last year.
For the year ended March 31, 2014, Alembic's net sales was up by 22 per cent to Rs 1868.4 crore. Net profit after tax for the same period was up by 43 per cent to Rs 235.5 crore. The Board has recommended dividend on equity shares at Rs 3 per share that is 150 per cent for 2013-14.
The India branded formulations business posted sales of Rs 199.5 crores against Rs 175.3 crores with a 14 per cent growth over the corresponding quarter of the previous year. International generic formulation posted growth of 76 per cent and posted sales of Rs 136.7 crore against Rs 77.7 crore over the corresponding quarter last year.
